Protective effects of renal ischemic preconditioning and adenosine pretreatment:: role of A1 and A3 receptors

被引:201
作者
Lee, HT [1 ]
Emala, CW [1 ]
机构
[1] Columbia Univ Coll Phys & Surg, Dept Anesthesiol, New York, NY 10032 USA
关键词
acute renal failure; adenosine; ischemic-reperfusion injury; kidney;
D O I
10.1152/ajprenal.2000.278.3.F380
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Renal ischemia and reperfusion during aortic and renal transplant surgery result in ischemic-reperfusion injury. Ischemic preconditioning and adenosine infusion before ischemia protect against ischemic-reperfusion injury in cardiac and skeletal muscle, but these protective phenomena have not been demonstrated in the kidney. Rats were randomized to sham operation, 45-min renal ischemia, ischemic preconditioning with four cycles of 8-min renal ischemia and 5-min reperfusion followed by 45-min renal ischemia, systemic adenosine pretreatment before 45-min renal ischemia, or pretreatments with selective adenosine receptor subtype agonists or antagonists before 45-min renal ischemia. Forty-five minutes of renal ischemia followed by 24 h of reperfusion resulted in marked rises in blood urea nitrogen and creatinine. Ischemic preconditioning and adenosine pretreatment protected renal function and improved renal morphology. A(1) adenosine receptor activation mimics and A(1) adenosine antagonism blocks adenosine-induced protection. In addition, A(3) adenosine receptor activation before renal ischemia worsens renal ischemic-reperfusion injury, and A(3) adenosine receptor antagonism protects renal function. We demonstrate for the first time that rat kidneys can be preconditioned to attenuate ischemic-reperfusion injury and adenosine infusion before ischemic insult protects renal function via A(1) adenosine receptor activation. Our data suggest that an A(1) adenosine agonist and A(3) adenosine antagonist may have clinically beneficial implications where renal ischemia is unavoidable.
引用
收藏
页码:F380 / F387
页数:8
相关论文
共 53 条
  • [1] Aronson S, 1998, J CARDIOTHOR VASC AN, V17, P117
  • [2] BEACH RE, 1999, KIDNEY INT, V39, P839
  • [3] CHARACTERIZATION OF ADENOSINE RECEPTORS IN BRUSH-BORDER MEMBRANES FROM PIG-KIDNEY
    BLANCO, J
    CANELA, EI
    MALLOL, J
    LLUIS, C
    FRANCO, R
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (03) : 671 - 678
  • [4] CELLULAR MECHANISMS OF ACUTE ISCHEMIC-INJURY IN THE KIDNEY
    BREZIS, M
    EPSTEIN, FH
    [J]. ANNUAL REVIEW OF MEDICINE, 1993, 44 : 27 - 37
  • [5] HYPOTHESIS - ADENOSINE MEDIATES HEMODYNAMIC-CHANGES IN RENAL-FAILURE
    CHURCHILL, PC
    BIDANI, AK
    [J]. MEDICAL HYPOTHESES, 1982, 8 (03) : 275 - 285
  • [6] RENAL EFFECTS OF SELECTIVE ADENOSINE RECEPTOR AGONISTS IN ANESTHETIZED RATS
    CHURCHILL, PC
    BIDANI, A
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 252 (02): : F299 - F303
  • [7] DINOUR D, 1993, EXP NEPHROL, V1, P152
  • [8] Systemic pretreatment with adenosine preserves rabbit renal function after ischemia and reperfusion
    Egan, JC
    Knolmayer, TJ
    Bowyer, MW
    Sun, LS
    Lee, HT
    [J]. ANESTHESIOLOGY, 1998, 89 (3A) : U335 - U335
  • [9] IMPROVED 4- AND 6-HOUR MYOCARDIAL PRESERVATION BY HYPOXIC PRECONDITIONING
    ENGELMAN, DT
    CHEN, C
    WATANABE, M
    ENGELMAN, RM
    ROUSOU, JA
    FLACK, JE
    DEATON, DW
    MAULIK, N
    DAS, DK
    [J]. CIRCULATION, 1995, 92 (09) : 417 - 422
  • [10] Frank R S, 1993, Ann Vasc Surg, V7, P150, DOI 10.1007/BF02001009